INBX (Inhibrx Biosciences) Long-Term Debt : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences Long-Term Debt?

Inhibrx Biosciences's Long-Term Debt for the quarter that ended in Dec. 2024 was $0.00 Mil.

Inhibrx Biosciences's annual Long-Term Debt increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($206.97 Mil) but then declined from Dec. 2023 ($206.97 Mil) to Dec. 2024 ($0.00 Mil).

Inhibrx Biosciences Long-Term Debt Historical Data

The historical data trend for Inhibrx Biosciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences Long-Term Debt Chart

Inhibrx Biosciences Annual Data

Trend

Dec22

Dec23

Dec24

Long-Term Debt

206.97

Inhibrx Biosciences Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial				206.97	-	-	-	-

Inhibrx Biosciences (NAS:INBX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Inhibrx Biosciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Inhibrx Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037

Website

https://www.inhibrx.com

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.